A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma

Cancer Chemotherapy and Pharmacology

Volumn 64, Issue 2, 2009, Pages 379-384

  Rubio, Joaquín Casal ^a   Vazquez S ^b   Vazquez F ^c   Amenedo, M ^d   Firvida J L ^e   Mel, J R ^b   Huidobro, G ^a   Alvarez E ^b   Lazaro M ^a   Alonso, G ^f   Fernandez I ^g  

^a HOSPITAL DO MEIXOEIRO   (Spain)

^b HOSPITAL XERAL CALDE   (Spain)

^c Universidad de La Coruña   (Spain)

^d Centro Oncologico de Galicia   (Spain)

^e Complejo Hospitalario ^*  (Spain)

^f HOSPITAL JUAN CANALEJO   (Spain)

^g HOSPITAL MONTECELO   (Spain)

Author keywords

Chemotherapy; Cisplatin; Docetaxel; Gemcitabine; Non small cell lung cancer; Phase II trial

Indexed keywords

CISPLATIN; DOCETAXEL; GEMCITABINE;

ADULT; ADVANCED CANCER; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG SENSITIVITY; DRUG TOLERABILITY; DRUG TOLERANCE; DYSPHAGIA; FATIGUE; FEMALE; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DEOXYCYTIDINE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67349141696     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0884-6     Document Type: Article

References (32)

1. N Donnadieu M Paesmans JP Sculier 1991 Chemotherapy of non-small cell bronchial cancers. Meta-analysis of the literature as a function of the extent of the disease Rev Mal Respir 8 197 204
2. Non-small Cell Lung Cancer Collaborative Group (1995) Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Bmj 311:899-909
3. KS Albain JJ Crowley M LeBlanc RB Livingston 1991 Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest oncology group experience J Clin Oncol 9 1618 1626
4. DG Pfister DH Johnson CG Azzoli 2004 American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003 J Clin Oncol 22 330 353 (Pubitemid 41095099)
5. JL Pujol F Barlesi JP Daures 2006 Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials Lung Cancer 51 335 345 (Pubitemid 43265817)
6. V Georgoulias E Papadakis A Alexopoulos 2001 Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial Lancet 357 1478 1484 (Pubitemid 32488857)
7. K Matsui T Hirashima T Nitta 2005 A phase I/II study comparing regimen schedules of gemcitabine and docetaxel in Japanese patients with stage IIIB/IV non-small cell lung cancer Jpn J Clin Oncol 35 181 187 (Pubitemid 40796851)
8. JL Pujol JL Breton R Gervais 2005 Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin Ann Oncol 16 602 610 (Pubitemid 40613327)
9. JR Rigas 2001 Non-platinum based combination chemotherapy: phase I and II trials of docetaxel plus gemcitabine, vinorelbine, or irinotecan Semin Oncol 28 15 20 (Pubitemid 32552974)
10. CH Spiridonidis LR Laufman L Carman 2001 Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: a phase II trial Ann Oncol 12 89 94 (Pubitemid 32162452)
11. RP Abratt WR Bezwoda G Falkson 1994 Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study J Clin Oncol 12 1535 1540 (Pubitemid 24244986)
12. RP Abratt WR Bezwoda L Goedhals DJ Hacking 1997 Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer J Clin Oncol 15 744 749 (Pubitemid 27074244)
13. A Anton N Diaz-Fernandez JL Gonzalez Larriba 1998 Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC) Lung Cancer 22 139 148 (Pubitemid 29050855)
14. F Cardenal MP Lopez-Cabrerizo A Anton 1999 Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer J Clin Oncol 17 12 18 (Pubitemid 29022372)
15. L Crino G Scagliotti M Marangolo 1997 Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study J Clin Oncol 15 297 303 (Pubitemid 27020587)
16. T Le Chevalier G Scagliotti R Natale 2005 Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes Lung Cancer 47 69 80 (Pubitemid 39643243)
17. C Kosmas N Tsavaris N Mylonakis HP Kalofonos 2003 An overview of current results with the gemcitabine and docetaxel combination as initial and salvage chemotherapy regimen in advanced non-small cell lung cancer Crit Rev Oncol Hematol 45 265 275 (Pubitemid 36299134)
18. N Hanna FA Shepherd FV Fossella 2004 Randomized phase iii trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy J Clin Oncol 22 1589 1597 (Pubitemid 41079796)
19. EF Smit K Mattson J von Pawel 2003 ALIMTA (R) (pemetrexed disodium) as second-line treatment of non-small-cell lung cancer: a phase II study Ann Oncol 14 455 460 (Pubitemid 36367425)
20. ER Brown FA Shepherd 2005 Erlotinib in the treatment of non-small cell lung cancer Expert Rev Anticancer Ther 5 767 775 (Pubitemid 41599953)
21. FA Shepherd J Rodrigues Pereira T Ciuleanu 2005 Erlotinib in previously treated non-small-cell lung cancer N Engl J Med 353 123 132 (Pubitemid 41058344)
22. F Fossella JR Pereira J von Pawel 2003 Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group J Clin Oncol 21 3016 3024 (Pubitemid 46606280)
23. FV Fossella 2002 Docetaxel in second-line treatment of non-small-cell lung cancer Clin Lung Cancer 3 suppl 2 S23 S28
24. Pocock SJ (1984) Clinical trials: a practical approach. Wiley Chichester
25. I Sekine K Kubota Y Nishiwaki 1998 Response rate as an endpoint for evaluating new cytotoxic agents in phase II trials of non-small-cell lung cancer Ann Oncol 9 1079 1084 (Pubitemid 28518145)
26. G D'Addario M Pintilie NB Leighl 2005 Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature J Clin Oncol 23 2926 2936 (Pubitemid 46224111)
27. V Georgoulias G Scagliotti V Miller 2001 Challenging the platinum combinations: docetaxel (Taxotere) combined with gemcitabine or vinorelbine in non-small cell lung cancer Semin Oncol 28 15 21 (Pubitemid 32234100)
28. J Casal M Amenedo JR Mel 2007 Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study Cancer Chemother Pharmacol 60 725 732 (Pubitemid 47248602)
29. V Hirsh R Whittom P Desjardins 2004 Docetaxel and Gemcitabine administered on days 1 and 8 for metastatic non-small cell lung carcinoma (NSCLC): a phase II multicenter trial Lung Cancer 46 113 118 (Pubitemid 39201390)
30. IE Popa K Stewart FP Smith NA Rizvi 2002 A phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced non-small-cell lung carcinoma Cancer 95 1714 1719
31. DV Skarlos AM Dimopoulos P Kosmidis 2003 Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group Lung Cancer 41 107 111 (Pubitemid 36765489)
32. V Georgoulias C Kouroussis N Androulakis 1999 Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial J Clin Oncol 17 914 920 (Pubitemid 29109323)